NewsFeed
November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
MRC LMS Highlights Josca Schoonejans’ Research on Gestational Diabetes Treatments
Nov 15, 2026, 16:45

MRC LMS Highlights Josca Schoonejans’ Research on Gestational Diabetes Treatments

MRC Laboratory of Medical Sciences (LMS) shared on LinkedIn:

“This World Diabetes Day, we’re shining a spotlight on Josca Schoonejans and her research into improving treatments for gestational diabetes.

Around 1 in 7 women worldwide develops gestational diabetes, a type of diabetes first diagnosed during pregnancy.

Metformin is a commonly used treatment and poses no immediate risk to parent or baby. However, questions remain about its potential long-term effects on babies exposed during pregnancy.

Josca’s research is exploring whether ursodeoxycholic acid (UDCA), a medication already used to treat liver conditions during pregnancy, could offer a safer alternative.

At the LMS, we’re working to understand the biology behind disease and use those insights to improve people’s health. Studies like this could help shape safer treatments for women with gestational diabetes and their babies in the future.

 

Stay informed with the latest updates in fertility and reproductive medicine on Fertility News.